This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Monitoring the impact of pneumococcal conjugate vaccination in The Gambia

January 17th, 2012

Grant MacKenzie of the MRC Unit in The Gambia and colleagues describe in this week's PLoS Medicine how they set up a population-based surveillance system to assess the impact of pneumococcal conjugate vaccines (PCVs) on invasive pneumococcal disease (IPD) and radiological pneumonia in children in The Gambia. The surveillance system is expected to inform immunisation policy and serves as a potential model for those introducing routine PCV vaccination in diverse settings.

The authors state: "Evidence of sustained reduction of IPD and radiological pneumonia due to PCVs is important to justify their introduction and ongoing use. Identification of emerging pneumococcal serotypes may also assist the design of future PCVs."

More information:
Mackenzie GA, Plumb ID, Sambou S, Saha D, Uchendu U, et al. (2012) Monitoring the Introduction of Pneumococcal Conjugate Vaccines into West Africa: Design and Implementation of a Population-Based Surveillance System. PLoS Med 9(1): e1001161. doi:10.1371/journal.pmed.1001161

Provided by Public Library of Science

Citation: Monitoring the impact of pneumococcal conjugate vaccination in The Gambia (2012, January 17) retrieved 9 August 2026 from https://sciencex.com/wire-news/88280749/monitoring-the-impact-of-pneumococcal-conjugate-vaccination-in-t.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.